PATENT CLAIM ANALYSIS

Application Number: 16013281
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["548", "530000"]

Abstract:
The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.

Claim (Index 35):
A compound of formula E wherein R is methyl, ethyl, benzyl, allyl, phenacyl, methoxymethyl, methylthiomethyl, 2-methoxyethoxymethyl, 2-trimethylsilylethyl or tert-butyldiphenylsilyl; and (i) R 8  is \u2014Cl or \u2014F; and\n R 9  is \u2014H; or \n (ii) R 8  is \u2014F; and\n R 9  is F.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.0
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13526337', '15624290', '14763468', '15039323', '15906268']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7879443831096276
- 35 USC 102 Novelty (BERT): 0.5508078793727855
- Combined Prediction Score: 0.7642307327359433
- Mean Citation Score: 343.29917
- Max Citation Score: 459.43094
- Similarity Product: 265.29824899781465

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test